Clinical Trial Update: A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination therapy including anti-PD-1 immunotherapy for advanced rectal cancer with distal metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Metastasis of Rectal Cancer
• Rectal Cancer

Drugs mentioned

• Anti-PD-1 immunotherapy

Snippet

Sponsor: LI XIN-XIANG | Conditions: Advanced Rectal Cancer, Distal Metastasis | Phase 2 | Status: UNKNOWN